Early surgery first for painful chronic pancreatitis with dilated main pancreatic duct: evidence awaiting integration into practice
Translational Gastroenterology and Hepatology · 2026-03 · 11 · 40-40
DOI: 10.21037/tgh-25-88 ↗Kurz gefasst
Editorial in der Zeitschrift Translational Gastroenterology and Hepatology, 2026-03. Verfasst von Vasileios K Mavroeidis. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, North Bristol NHS Trust, Southmead Hospital, Bristol, UK. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
6 months for weak opioids and 2 months for strong opioids. Patients were randomised to undergo early surgery or a step-up endoscopy-first approach as part of the ESCAPE RCT (3). The initial publication reported
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, North Bristol NHS Trust, Southmead Hospital, Bristol, UK.
- Department of Transplant Surgery, North Bristol NHS Trust, Southmead Hospital, Bristol, UK.
- Department of HPB Surgery, University Hospitals Bristol & Weston NHS Foundation Trust, Bristol Royal Infirmary, Bristol, UK.
ORCID-Profile: Vasileios K Mavroeidis
Zitieren
APA
Mavroeidis, V. K. (2026). Early surgery first for painful chronic pancreatitis with dilated main pancreatic duct: evidence awaiting integration into practice. Translational Gastroenterology and Hepatology, 11, 40-40. https://doi.org/10.21037/tgh-25-88
Vancouver
Mavroeidis VK. Early surgery first for painful chronic pancreatitis with dilated main pancreatic duct: evidence awaiting integration into practice. Translational Gastroenterology and Hepatology. 2026;11:40-40. doi:10.21037/tgh-25-88
BibTeX
@article{Mavroeidis2026,
author = {Mavroeidis, Vasileios K},
title = {Early surgery first for painful chronic pancreatitis with dilated main pancreatic duct: evidence awaiting integration into practice},
journal = {Translational Gastroenterology and Hepatology},
year = {2026},
volume = {11},
pages = {40--40},
doi = {10.21037/tgh-25-88}
}
EUVIMED